XML 83 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions and Divestitures - Narrative (Details)
$ in Millions, € in Billions
2 Months Ended 3 Months Ended 8 Months Ended 12 Months Ended
Nov. 01, 2022
USD ($)
Apr. 29, 2022
EUR (€)
Apr. 29, 2022
USD ($)
Dec. 31, 2022
USD ($)
Apr. 01, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Business Acquisition [Line Items]                  
Increase (decrease) in goodwill from measurement period adjustments             $ 80.6    
Goodwill       $ 3,490.4   $ 3,490.4 3,529.1 $ 3,490.4 $ 2,999.4
Business acquisitions               559.5  
CSCA                  
Business Acquisition [Line Items]                  
Increase (decrease) in goodwill from measurement period adjustments             35.2    
Goodwill       2,044.4   2,044.4 2,080.9 2,044.4 1,902.4
Business acquisitions     $ 141.7         141.7  
CSCI                  
Business Acquisition [Line Items]                  
Increase (decrease) in goodwill from measurement period adjustments             45.4    
Goodwill       1,446.0   1,446.0 $ 1,448.2 1,446.0 $ 1,097.0
Business acquisitions     $ 417.8         417.8  
Developed product technology                  
Business Acquisition [Line Items]                  
Useful life of intangible assets             11 years    
HRA Pharma                  
Business Acquisition [Line Items]                  
Percentage of interest acquired     100.00%            
Purchase Price   € 1.8 $ 1,945.6            
Net sales since acquisition           193.6      
Net income (loss) since acquisition           (59.4)      
Cost of sales of acquiree since acquisition           23.8      
Assets of acquiree since acquisition date           $ 67.6      
General transaction costs               46.9  
Increase (decrease) in goodwill from measurement period adjustments         $ 80.6        
Decrease in-definite lived intangibles from measurement period adjustments         104.3        
Decrease in deferred income tax liabilities from measurement period adjustments         27.2        
Net increase in other non-current liabilities from measurement period adjustments         2.0        
Decrease in prepaid expenses and other current assets from measurement period adjustments         $ 1.5        
Cost of sales               3.5  
Goodwill     $ 559.5            
HRA Pharma | Trademarks and trade names                  
Business Acquisition [Line Items]                  
Useful life of intangible assets   20 years 20 years            
HRA Pharma | Developed product technology | Minimum                  
Business Acquisition [Line Items]                  
Useful life of intangible assets   8 years 8 years            
HRA Pharma | Developed product technology | Maximum                  
Business Acquisition [Line Items]                  
Useful life of intangible assets   18 years 18 years            
HRA Pharma | Distribution networks | Minimum                  
Business Acquisition [Line Items]                  
Useful life of intangible assets   2 years 2 years            
HRA Pharma | Distribution networks | Maximum                  
Business Acquisition [Line Items]                  
Useful life of intangible assets   21 years 21 years            
Nestlé’s Gateway Infant Formula Plant and Good Start® infant formula                  
Business Acquisition [Line Items]                  
Purchase Price $ 110.0                
Net sales since acquisition       42.7          
Net income (loss) since acquisition       11.5          
Cost of sales of acquiree since acquisition       $ 7.9          
General transaction costs               $ 4.9  
Useful life of intangible assets 13 years 3 months 18 days